Evoke Pharma (NASDAQ:EVOK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Evoke Pharma beat estimated earnings by 37.5%, reporting an EPS of $-0.05 versus an estimate of $-0.08.
Revenue was up $337.55 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 13.64% drop in the share price the next day.
Here's a look at Evoke Pharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.08 | -0.06 | -0.13 |
| EPS Actual | -0.06 | -0.07 | -0.08 | -0.09 |
| Revenue Estimate | 380.00K | 150.00K | 830.00K | 840.00K |
| Revenue Actual | 930.45K | 236.63K | 90.42K | 23.02K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
